# Treatment of Uterine Fibroids With Asoprisnil(J867)

> **NCT00152269** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 475 (actual)

## Conditions studied

- Leiomyoma
- Menorrhagia
- Metrorrhagia

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00152269
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152269, "Treatment of Uterine Fibroids With Asoprisnil(J867)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00152269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*